确保在面部血管化复合性全体移植中确保种族和民族的包容性
Martin Kauke-Navarro1, Leonard Knoedler1,2, Samuel Knoedler3,4
1From the Division of Plastic Surgery, Department of Surgery, Yale New Haven Hospital, Yale School of Medicine, New Haven, Conn.
Plastic and reconstructive surgery. Global open
|August 14, 2023
概括
在面部血管化复合性全移植 (fVCA) 中可能存在种族和民族差异. 美国fVCA接受者的人口统计数据不成比例地反映出一般人口,这表明潜在的医疗保健失衡.
科学领域:
- 整形外科 整形外科 整形外科
- 移植手术 移植手术
- 健康差距 研究 研究 研究 研究
背景情况:
- 面部血管化复合性全移植 (fVCA) 是面部严重缺陷的关键重建性手术.
- 现有证据表明,在各种医疗程序中存在医疗保健差异.
- 在fVCA中的种族和民族代表性尚未被彻底检查.
研究的目的:
- 调查面部血管化复合性全移植 (fVCA) 中潜在的种族和民族差异.
- 分析全球和美国fVCA接受者的人口分布.
主要方法:
- 使用PubMed/MEDLINE和Embase数据库进行了全面的文献审查.
- 搜索包括与面部移植和血管化复合性全移植相关的术语.
- 从数据库创建到2022年12月1日,收集了英语和法语出版的研究数据.
主要成果:
- 对全球47例fVCA病例 (2005-2020年) 的分析显示,36例是白人,10例是亚洲人,1例是黑人.
- 在美国,17项fVCA手术中有16项涉及白人患者;一名黑人接受者占美国病例的6%.
- 接受fVCA的种族和民族分布并不反映美国一般人口统计数据.
结论:
- 目前fVCA的种族和民族分布表明存在医疗保健失衡的风险.
- 需要进一步的大规模研究来证实这些发现.
- 需要采取积极的措施来防止差距,对fVCA的访问障碍的研究是必不可少的.
更多相关视频
09:09A Modified Heterotopic Swine Hind Limb Transplant Model for Translational Vascularized Composite Allotransplantation VCA Research
Published on: October 14, 2013
12.5K
09:36Modified Heterotopic Hindlimb Osteomyocutaneous Flap Model in the Rat for Translational Vascularized Composite Allotransplantation Research
Published on: April 26, 2019
5.9K
相关概念视频
01:24Tissue Transplantation
396
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
396
01:22Bone Marrow Sampling and Transplants
360
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
360